Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). (Q43219125)

16 November 2017

title

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). (English)

1 reference

16 November 2017

1 reference

1 reference

16 November 2017

1 reference

16 November 2017

Carmen Schade-Brittinger

object named as

Carmen Schade-Brittinger

1 reference

16 November 2017

Günther Deuschl

1 reference

16 November 2017

Thomas Klockgether

1 reference

16 November 2017

Claudia Trenkwalder

1 reference

16 November 2017

Friederike Sixel-Döring

object named as

Friederike Sixel-Döring

1 reference

16 November 2017

Thomas Gasser

1 reference

16 November 2017

Werner Poewe

1 reference

16 November 2017

Gregor Wenning

1 reference

16 November 2017

Klaus Seppi

1 reference

16 November 2017

Wolfgang H Oertel

1 reference

16 November 2017

Karla Eggert

1 reference

16 November 2017

Richard Dodel

1 reference

16 November 2017

Annika Spottke

1 reference

16 November 2017

Nicole Schimke

1 reference

16 November 2017

Christoph Kamm

1 reference

16 November 2017

Martin Sawires

1 reference

16 November 2017

Felix Geser

1 reference

16 November 2017

Martin Köllensperger

1 reference

16 November 2017

Christine Daniels

1 reference

16 November 2017

Alexander Gerhard

1 reference

16 November 2017

Alexander Reuss

1 reference

16 November 2017

Sylvia Reinecker

1 reference

16 November 2017

Birgit Herting

1 reference

16 November 2017

Manja Kloss

1 reference

16 November 2017

Martin Krause

1 reference

16 November 2017

Silke Böttger

1 reference

16 November 2017

Markus Naumann

1 reference

16 November 2017

Axel Lipp

1 reference

16 November 2017

Doreen Gruber

1 reference

16 November 2017

Andreas Kupsch

1 reference

16 November 2017

Yansheng Du

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

16 November 2017

1 reference

16 November 2017

1 reference

16 November 2017

1 reference

16 November 2017

page(s)

97-107

1 reference

16 November 2017

cites work

Multiple system atrophy

1 reference

Microglial activation parallels system degeneration in multiple system atrophy

21 January 2018

1 reference

Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins.

21 January 2018

1 reference

Cell death mechanisms in multiple system atrophy

21 January 2018

1 reference

Microglia: phagocyte and glia cell.

21 January 2018

1 reference

Degeneration of neuronal cells due to oxidative stress--microglial contribution

21 January 2018

1 reference

[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

21 January 2018

1 reference

Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine

21 January 2018

1 reference

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

21 January 2018

1 reference

Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury

21 January 2018

1 reference

Minocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomy.

21 January 2018

1 reference

Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus

21 January 2018

1 reference

Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice

21 January 2018

1 reference

Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction

21 January 2018

1 reference

Rise and fall of minocycline in neuroprotection: need to promote publication of negative results

21 January 2018

1 reference

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

21 January 2018

1 reference

Neuroprotection in Huntington's disease: a 2-year study on minocycline

21 January 2018

1 reference

Maintained improvement with minocycline of a patient with advanced Huntington's disease

21 January 2018

1 reference

Minocycline in amyotrophic lateral sclerosis: a pilot study

21 January 2018

1 reference

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

21 January 2018

1 reference

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

21 January 2018

1 reference

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).

21 January 2018

1 reference

EQ-5D: a measure of health status from the EuroQol Group

21 January 2018

1 reference

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

21 January 2018

1 reference

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures

21 January 2018

1 reference

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

21 January 2018

1 reference

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

21 January 2018

1 reference

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

21 January 2018

1 reference

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy

21 January 2018

1 reference

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22732

1 reference

16 November 2017

1 reference